Silo Pharma shares are trading higher after the company announced a share repurchase program to acquire up to $1 million of its common stock, signaling confidence in its growth strategy.

New Pacific Metals shares are trading higher after announcing a Framework Agreement for Cooperation with the Carangas Community, advancing its Carangas silver-gold project in Bolivia.

Genprex shares are trading higher after the company secured new patents in Japan and the EU for its Reqorsa4 gene therapy in combination with immunotherapies to treat cancer.

Safe Pro Group shares are trading higher after the company projected over 500% year-over-year revenue growth for Q1 2026, driven by a U.S. Government award for AI edge processing systems.

Stepan Company shares are trading lower after the company reported a decline in net income for the full year 2025, despite an increase in net sales. The company also announced a $100 million pre-tax cost efficiency plan, which includes plant closures and asset decommissioning.

Allurion Technologies shares are trading higher after the FDA approved the premarket application for the Allurion Gastric Balloon System.

ImmunityBio shares are trading higher after the company announced multiple global regulatory approvals for ANKTIVA, including a significant conditional accelerated approval from the SFDA for metastatic NSCLC, marking its first lung cancer authorization worldwide.

United Homes Group shares are trading lower after the announcement of its acquisition by Stanley Martin Homes for $1.18 per share in an all-cash deal, causing concern among investors about future delisting and reduced liquidity options.

EHAB shares are trading higher after the company announced it will be acquired by Kinderhook Industries in an all-cash transaction valued at approximately $1.1 billion.

Veris Residential shares are trading higher after the company announced it will be acquired by an Affinius Capital-led investor consortium for $3.4 billion in cash, offering a 23.2% premium per share.

Airgain shares are trading higher after the company announced a multi-year, multi-million-dollar embedded antenna design win for a next-generation 5G home connectivity platform with a major North American Mobile Network Operator.

Arcellx shares are trading higher after Gilead Sciences announced a definitive agreement to acquire the company for $115 per share in cash, reflecting a 68% premium to its 30-day volume-weighted average price.

TOMI Environmental Solutions shares are trading higher after the company received biocidal product approvals in Great Britain and Northern Ireland for its Binary Ionization Technology (BIT) solution and SteraMist iHP brand.

Faraday Future shares are trading higher after the company announced it will officially begin its first batch of EAI robotics deliveries next week.

MoonLake shares are trading higher after announcing positive topline results from its Phase 2 clinical trial of sonelokimab in axial spondyloarthritis, with over 80% of patients achieving significant clinical improvements by Week 12.

Vanda Pharmaceuticals shares are trading higher after the FDA approved BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia, marking a significant step in psychiatric innovation.

Psyence BioMed shares are trading higher after the company announced the exercise of a put option by PsyLabs, resulting in a strategic equity investment.

Grail Inc. shares are trading lower after the company's NHS-Galleri trial failed to meet its primary clinical endpoint, resulting in a 48% decline in after-hours trading.

Rimini Street shares are trading higher after the company announced strong fiscal fourth-quarter and annual 2025 financial results, exceeding guidance and seeing solid growth in core subscription billings.

Eldorado Gold shares are trading lower after the company announced that first concentrate production at its Skouries project has been delayed, impacting capital expenditures and future cash flows.